Package 42571-274-60

{"route": ["ORAL"], "spl_id": "336d06cd-6aab-a167-e063-6294a90ad16d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0342571274603"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["111a4f6a-c3e4-43e2-8f0e-8c72f71cddb2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60)", "package_ndc": "42571-274-60", "marketing_start_date": "20210816"}], "brand_name": "ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "product_id": "42571-274_336d06cd-6aab-a167-e063-6294a90ad16d", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42571-274", "generic_name": "ASPIRIN and Extended-Release DIPYRIDAMOLE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA209929", "marketing_category": "ANDA", "marketing_start_date": "20210816", "listing_expiration_date": "20261231"}